Common name
methylcyclopropane
IUPAC name
methylcyclopropane
SMILES
CC1CC1
Common name
methylcyclopropane
IUPAC name
methylcyclopropane
SMILES
CC1CC1
INCHI
InChI=1S/C4H8/c1-4-2-3-4/h4H,2-3H2,1H3
FORMULA
C4H8
Common name
methylcyclopropane
IUPAC name
methylcyclopropane
Molecular weight
56.106
clogP
1.674
clogS
-0.678
Frequency
0.0038
HBond Acceptor
0
HBond Donor
0
Total PolarSurface Area
0
Number of Rings
1
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00084 | Betaxolol |
|
Antihypertensive Agents; Adrenergic beta-1 Receptor Antagonists; Sympatholytics; EENT Preparations; Ophthalmologicals; Sensory Organs; Cardiovascular System; Beta Blocking Agents, Selective; Beta Blocking Agents; Antiglaucoma Preparations and Miotics; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); | For the management of hypertension. |
| FDBD00344 | Montelukast |
|
Anti-Asthmatic Agents; Anti-Arrhythmia Agents; Respiratory System; Drugs for Obstructive Airway Diseases; Leukotriene Receptor Antagonists; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of asthma. |
| FDBD00568 | Naltrexone |
|
Appetite Depressants; Narcotic Antagonists; Central Nervous System Depressants; Alcohol Antagonists; Alimentary Tract and Metabolism; Nervous System; Drugs Used in Addictive Disorders; Centrally Acting Antiobesity Products; Antiobesity Preparations, Excl. Diet Products; Drugs Used in Alcohol Dependence; | Used as an adjunct to a medically supervised behaviour modification program in the maintenance of opiate cessation in individuals who were formerly physically dependent on opiates and who have successfully undergone detoxification. Also used for the management of alcohol dependence in conjunction with a behavioural modification program. |
| FDBD00778 | Buprenorphine |
|
Analgesics; Analgesics, Opioid; Narcotics; Narcotic Antagonists; Nervous System; Drugs Used in Addictive Disorders; Opioids; Drugs Used in Opioid Dependence; Oripavine Derivatives; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; | For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence. |
| FDBD01239 | Prazepam |
|
Anti-Anxiety Agents; GABA Modulators; Nervous System; Benzodiazepine Derivatives; Anxiolytics; Psycholeptics; CYP3A4 Inhibitors; | For the treatment of anxiety disorders. |
| FDBD01279 | Roflumilast |
|
Respiratory System; Drugs for Obstructive Airway Diseases; | Roflumilast is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Roflumilast is not a bronchodilator and is not indicated for the relief of acute bronchospasm. |
| FDBD01493 | Methylnaltrexone |
|
Narcotic Antagonists; Alimentary Tract and Metabolism; Drugs for Constipation; Peripheral Opioid Receptor Antagonists; CYP2D6 Inducers; CYP2D6 Inducers (strong); | Treatment of opioids induced constipation in palliative patients that are inadequately responding to laxative therapy. |
| FDBD01656 | Tasimelteon |
|
Hypnotics and Sedatives; Nervous System; Psycholeptics; Melatonin Receptor Agonists; | Tasimelteon is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD). |
| FDBD01823 | Levobetaxolol |
|
; | |
| FDBD02307 | protrifenbute |
|
Insecticide | Insecticide |
11 ,
2
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 2xda_ligand_1_0.mol2 | 2xda | 1 | -6.38 | CC1CC1 | 4 |
| 4n6h_ligand_1_1.mol2 | 4n6h | 1 | -6.25 | CC1CC1 | 4 |
| 1xmu_ligand_1_0.mol2 | 1xmu | 1 | -6.11 | C1CC1C | 4 |
| 3cs7_ligand_1_1.mol2 | 3cs7 | 1 | -6.11 | C1(CC1)C | 4 |
| 4c36_ligand_1_1.mol2 | 4c36 | 1 | -6.11 | CC1CC1 | 4 |
| 1xoq_ligand_1_0.mol2 | 1xoq | 1 | -6.06 | CC1CC1 | 4 |
| 2f9v_ligand_1_11.mol2 | 2f9v | 1 | -6.05 | C1(CC1)C | 4 |
| 3g4l_ligand_1_0.mol2 | 3g4l | 1 | -6.05 | C1CC1C | 4 |
2760 ,
277
